Position in IMVT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,788,877
+$11,137,390 QoQ
Shares Held
331,920
+399.2% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#37
of 226 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. IMVT ranks #20 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,089,376 | $81,136,724 | |
| 2 | INSM |
INSMED Inc
|
689,981 | $73,565,774 | |
| 3 | EXEL |
Exelixis, Inc.
|
929,242 | $50,560,057 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
84,634 | $45,444,226 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
178,491 | $43,689,242 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
498,655 | $40,645,369 | |
| 7 | ABVX |
Abivax S.A.
|
270,612 | $36,061,755 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
622,603 | $34,205,808 |
All Filings in IMVT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,788,877 | 331,920 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,651,487 | 66,485 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,156,632 | 84,840 | Shares | Defined | 2026-02-12 | |
| 2023-12-31 | $3,906,757 | 92,731 | Shares | Defined | 2024-02-09 | |
| 2022-09-30 | $801,790 | 143,690 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $512,126 | 92,945 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $774,289 | 90,879 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,119,325 | 243,881 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,890,381 | 178,844 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||